Latest Breaking News On - Aiolos bio inc - Page 1 : comparemela.com

GSK s Experimental Asthma Drug Reduces Severe Attacks, Phase 3 Trial Data Shows

GSK s Experimental Asthma Drug Reduces Severe Attacks, Phase 3 Trial Data Shows
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Aiolos bio inc

AstraZeneca to buy Canadian Fusion Pharma for up to $2 4 billion

AstraZeneca to buy Canadian Fusion Pharma for up to $2 4 billion
financialpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialpost.com Daily Mail and Mail on Sunday newspapers.

British columbiaLake louiseNew yorkUnited statesCity ofUnited kingdomMartin shkreliPaul ellisDavid rosenbergPascal soriotJack mintzMark purcellAlisa phamHargreaves lansdownAmolyt pharmaJustin trudeau

Big Pharma targeting smaller companies, with megadeals now out of favor – Indianapolis Business Journal

Indianapolis-based Eli Lilly and Co. and Switzerland-based Novartis were the most active acquirers in the past 12 months, with seven and six deals respectively, according to data compiled by Bloomberg.

Wouter joustraVersanis bioAiolos bio incAmbrx biopharma incInhibrx incSigilon therapeutics incEli lillyAmbrx biopharmaAiolos bioSwitzerland based novartisPoint biopharma globalSigilon therapeutics

Big Pharma Targets Smaller Companies With Megadeals Out of Favor

Big Pharma Targets Smaller Companies With Megadeals Out of Favor
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

Emma walmsleyWouter joustraAlcon incPfizer incJpmorgan health conferenceEli lilly coSandoz groupHaleon plcAmbrx biopharma incAiolos bio incAmgen incInhibrx incAmbrx biopharmaAiolos bioBiotech deal surge dials up buzzHorizon therapeutics

Big Pharma Targets Smaller Companies With Megadeals Out of Favor

Some drugmakers are doubling down on prescription medicines, shedding businesses they view as peripheral.

Wouter joustraEmma walmsleyEli lilly coAlcon incInhibrx incSandoz groupHaleon plcPfizer incAmbrx biopharma incAiolos bio incAmgen incAmbrx biopharmaAiolos bioHorizon therapeuticsChief executive officer vas narasimhan